

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.54011911 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.42485714 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.68862903 |
| 4 | myofibril assembly (GO:0030239) | 7.19779397 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.13084981 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.03213164 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.00570086 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.67288871 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 6.66736061 |
| 10 | endothelium development (GO:0003158) | 6.65450304 |
| 11 | cardiac muscle contraction (GO:0060048) | 6.51032166 |
| 12 | aggressive behavior (GO:0002118) | 6.32472670 |
| 13 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.32284286 |
| 14 | regulation of relaxation of muscle (GO:1901077) | 6.07489418 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.02325975 |
| 16 | cardiac muscle cell development (GO:0055013) | 6.00301823 |
| 17 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.89159272 |
| 18 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.71140211 |
| 19 | plasma membrane repair (GO:0001778) | 5.69962431 |
| 20 | cardiac cell development (GO:0055006) | 5.63799143 |
| 21 | epithelial cell differentiation involved in kidney development (GO:0035850) | 5.48795273 |
| 22 | regulation of female receptivity (GO:0045924) | 5.48513862 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.45727248 |
| 24 | muscle filament sliding (GO:0030049) | 5.42289526 |
| 25 | actin-myosin filament sliding (GO:0033275) | 5.42289526 |
| 26 | actomyosin structure organization (GO:0031032) | 5.31652930 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.31027658 |
| 28 | angiogenesis involved in wound healing (GO:0060055) | 5.25476325 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.23768140 |
| 30 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.20051643 |
| 31 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.15821420 |
| 32 | heart trabecula formation (GO:0060347) | 5.15750568 |
| 33 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.14462822 |
| 34 | carnitine shuttle (GO:0006853) | 5.07319011 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.05481189 |
| 36 | adult heart development (GO:0007512) | 5.03231839 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 5.02483715 |
| 38 | regulation of sarcomere organization (GO:0060297) | 5.02250219 |
| 39 | regulation of skeletal muscle contraction (GO:0014819) | 5.01157381 |
| 40 | seminiferous tubule development (GO:0072520) | 4.99158026 |
| 41 | cell communication involved in cardiac conduction (GO:0086065) | 4.94891699 |
| 42 | striated muscle hypertrophy (GO:0014897) | 4.86620741 |
| 43 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.81026832 |
| 44 | female mating behavior (GO:0060180) | 4.79823484 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.77914423 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 4.77664314 |
| 47 | regulation of hexokinase activity (GO:1903299) | 4.75070722 |
| 48 | regulation of glucokinase activity (GO:0033131) | 4.75070722 |
| 49 | striated muscle contraction (GO:0006941) | 4.68977502 |
| 50 | heart contraction (GO:0060047) | 4.64503308 |
| 51 | heart process (GO:0003015) | 4.64503308 |
| 52 | regulation of membrane repolarization (GO:0060306) | 4.63507532 |
| 53 | muscle tissue morphogenesis (GO:0060415) | 4.60291088 |
| 54 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.58783822 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.58218101 |
| 56 | regulation of coenzyme metabolic process (GO:0051196) | 4.58218101 |
| 57 | regulation of the force of heart contraction (GO:0002026) | 4.54890488 |
| 58 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.54361025 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.52847298 |
| 60 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.49446194 |
| 61 | actin-mediated cell contraction (GO:0070252) | 4.49425389 |
| 62 | fatty acid transmembrane transport (GO:1902001) | 4.40774603 |
| 63 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.34129069 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 4.28793017 |
| 65 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.28237779 |
| 66 | regulation of cardiac muscle contraction (GO:0055117) | 4.27811330 |
| 67 | NADH metabolic process (GO:0006734) | 4.27224218 |
| 68 | muscle hypertrophy (GO:0014896) | 4.27195759 |
| 69 | response to interferon-beta (GO:0035456) | 4.22403614 |
| 70 | relaxation of cardiac muscle (GO:0055119) | 4.19766164 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.18896011 |
| 72 | glomerular filtration (GO:0003094) | 4.18360368 |
| 73 | respiratory electron transport chain (GO:0022904) | 4.17039802 |
| 74 | grooming behavior (GO:0007625) | 4.16478489 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.13116086 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 4.13116086 |
| 77 | cell communication by electrical coupling (GO:0010644) | 4.12754898 |
| 78 | electron transport chain (GO:0022900) | 4.05047361 |
| 79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.04124382 |
| 80 | cardiac muscle cell action potential (GO:0086001) | 4.02184235 |
| 81 | negative regulation of potassium ion transport (GO:0043267) | 4.01960801 |
| 82 | regulation of heart rate (GO:0002027) | 4.01745201 |
| 83 | positive regulation of vasculogenesis (GO:2001214) | 3.98970158 |
| 84 | hyperosmotic salinity response (GO:0042538) | 3.96599733 |
| 85 | regulation of sequestering of triglyceride (GO:0010889) | 3.93523744 |
| 86 | oxygen transport (GO:0015671) | 3.91219045 |
| 87 | oxidative phosphorylation (GO:0006119) | 3.90964373 |
| 88 | positive regulation of odontogenesis (GO:0042482) | 3.87751242 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.84527769 |
| 90 | cardiac conduction (GO:0061337) | 3.77782856 |
| 91 | creatine metabolic process (GO:0006600) | 3.76829061 |
| 92 | regulation of heart contraction (GO:0008016) | 3.76156531 |
| 93 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.75702183 |
| 94 | regulation of sulfur metabolic process (GO:0042762) | 3.75652789 |
| 95 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.73935652 |
| 96 | cell differentiation involved in metanephros development (GO:0072202) | 3.71191808 |
| 97 | Peyers patch development (GO:0048541) | 3.70610917 |
| 98 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.70610917 |
| 99 | regulation of germinal center formation (GO:0002634) | 3.69986254 |
| 100 | carnitine transmembrane transport (GO:1902603) | 3.67938377 |
| 101 | negative regulation of B cell apoptotic process (GO:0002903) | 3.67234328 |
| 102 | regulation of cardioblast differentiation (GO:0051890) | 3.67187665 |
| 103 | thrombin receptor signaling pathway (GO:0070493) | 3.63965422 |
| 104 | positive regulation of cation channel activity (GO:2001259) | 3.62668976 |
| 105 | endothelial cell proliferation (GO:0001935) | 3.61191544 |
| 106 | detection of calcium ion (GO:0005513) | 3.58733363 |
| 107 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.58098731 |
| 108 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.58098731 |
| 109 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.58078698 |
| 110 | regulation of ATPase activity (GO:0043462) | 3.57660002 |
| 111 | regulation of ATP catabolic process (GO:1903289) | 3.57660002 |
| 112 | ventricular cardiac muscle cell development (GO:0055015) | 3.55985672 |
| 113 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.55820871 |
| 114 | positive regulation of heart contraction (GO:0045823) | 3.53580126 |
| 115 | natural killer cell mediated immunity (GO:0002228) | 3.53102254 |
| 116 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.53102254 |
| 117 | positive regulation of heart rate (GO:0010460) | 3.52897188 |
| 118 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.52840147 |
| 119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.52469476 |
| 120 | renal filtration (GO:0097205) | 3.52235770 |
| 121 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.51443174 |
| 122 | muscle hypertrophy in response to stress (GO:0003299) | 3.51443174 |
| 123 | cardiac muscle adaptation (GO:0014887) | 3.51443174 |
| 124 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.50979380 |
| 125 | ubiquinone biosynthetic process (GO:0006744) | 3.46526617 |
| 126 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.43862549 |
| 127 | regulation of fatty acid oxidation (GO:0046320) | 3.41776987 |
| 128 | actin filament-based movement (GO:0030048) | 3.39466691 |
| 129 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.39340275 |
| 130 | negative regulation of protein localization to cell surface (GO:2000009) | 3.39297398 |
| 131 | autophagic vacuole fusion (GO:0000046) | 3.38281340 |
| 132 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.37578808 |
| 133 | trabecula formation (GO:0060343) | 3.36500353 |
| 134 | mismatch repair (GO:0006298) | 3.35926968 |
| 135 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.35602980 |
| 136 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.35602980 |
| 137 | carnitine transport (GO:0015879) | 3.33339573 |
| 138 | amino-acid betaine transport (GO:0015838) | 3.33339573 |
| 139 | aspartate family amino acid catabolic process (GO:0009068) | 3.33252337 |
| 140 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.32548595 |
| 141 | branched-chain amino acid catabolic process (GO:0009083) | 3.28001283 |
| 142 | mature B cell differentiation involved in immune response (GO:0002313) | 3.27507888 |
| 143 | regulation of B cell apoptotic process (GO:0002902) | 3.21741222 |
| 144 | ribosomal small subunit assembly (GO:0000028) | 3.20797929 |
| 145 | hematopoietic stem cell proliferation (GO:0071425) | 3.20110347 |
| 146 | heparin biosynthetic process (GO:0030210) | 3.18951180 |
| 147 | heparin metabolic process (GO:0030202) | 3.18951180 |
| 148 | regulation of histone phosphorylation (GO:0033127) | 3.18108551 |
| 149 | dopamine transport (GO:0015872) | 3.16754713 |
| 150 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.16390216 |
| 151 | adenosine metabolic process (GO:0046085) | 3.14140795 |
| 152 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.07409859 |
| 153 | regulation of helicase activity (GO:0051095) | 3.06384658 |
| 154 | deoxyribonucleotide catabolic process (GO:0009264) | 3.05265223 |
| 155 | branched-chain amino acid metabolic process (GO:0009081) | 3.04044799 |
| 156 | GTP biosynthetic process (GO:0006183) | 2.98481436 |
| 157 | parental behavior (GO:0060746) | 2.98410509 |
| 158 | arginine catabolic process (GO:0006527) | 2.98377068 |
| 159 | regulation of respiratory burst (GO:0060263) | 2.98352935 |
| 160 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.93102748 |
| 161 | deoxyribose phosphate catabolic process (GO:0046386) | 2.92878358 |
| 162 | regulation of thymocyte apoptotic process (GO:0070243) | 2.91836081 |
| 163 | ubiquinone metabolic process (GO:0006743) | 2.90397039 |
| 164 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.88035070 |
| 165 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.87490526 |
| 166 | regulation of transmission of nerve impulse (GO:0051969) | 2.87471863 |
| 167 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.87385703 |
| 168 | DNA deamination (GO:0045006) | 2.86868862 |
| 169 | rRNA modification (GO:0000154) | 2.82821837 |
| 170 | maternal behavior (GO:0042711) | 2.82272387 |
| 171 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.82258983 |
| 172 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80814757 |
| 173 | definitive hemopoiesis (GO:0060216) | 2.79021252 |
| 174 | regulation of telomerase activity (GO:0051972) | 2.78047364 |
| 175 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77843362 |
| 176 | response to vitamin E (GO:0033197) | 2.77167158 |
| 177 | UTP biosynthetic process (GO:0006228) | 2.75279255 |
| 178 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74499884 |
| 179 | nuclear envelope reassembly (GO:0031468) | 2.74499884 |
| 180 | ventricular system development (GO:0021591) | 2.74290844 |
| 181 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.73185881 |
| 182 | regulation of vasculogenesis (GO:2001212) | 2.69719337 |
| 183 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.69217389 |
| 184 | L-methionine salvage (GO:0071267) | 2.68498708 |
| 185 | L-methionine biosynthetic process (GO:0071265) | 2.68498708 |
| 186 | amino acid salvage (GO:0043102) | 2.68498708 |
| 187 | regulation of B cell differentiation (GO:0045577) | 2.68482284 |
| 188 | UTP metabolic process (GO:0046051) | 2.68359245 |
| 189 | negative regulation of telomere maintenance (GO:0032205) | 2.67134058 |
| 190 | negative regulation of granulocyte differentiation (GO:0030853) | 2.65216865 |
| 191 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.65210557 |
| 192 | platelet dense granule organization (GO:0060155) | 2.64324428 |
| 193 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.64233221 |
| 194 | negative regulation of translational initiation (GO:0045947) | 2.64007378 |
| 195 | histamine secretion (GO:0001821) | 2.63378961 |
| 196 | DNA double-strand break processing (GO:0000729) | 2.61911644 |
| 197 | sleep (GO:0030431) | 2.59801621 |
| 198 | base-excision repair, AP site formation (GO:0006285) | 2.58034767 |
| 199 | quinone biosynthetic process (GO:1901663) | 2.57837961 |
| 200 | behavioral response to ethanol (GO:0048149) | 2.56752817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 9.78318181 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10000884 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.76388738 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.40060063 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.94176618 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.75790397 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.74085434 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.74085434 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52859220 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.47215435 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.31016245 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.11210775 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.95782796 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.90890547 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70767257 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66589531 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.64702875 |
| 18 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.64659135 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.55018138 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.35326124 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35019404 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.32626605 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.20023263 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.10464457 |
| 25 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.08957656 |
| 26 | MYC_18940864_ChIP-ChIP_HL60_Human | 2.08542016 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07491272 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05537893 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.99434094 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97482997 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94635276 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94333023 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93916188 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.93747000 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92650497 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90543370 |
| 37 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85807193 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84043413 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83711362 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.78437954 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78305128 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77087534 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75399083 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73381005 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71319760 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66059993 |
| 47 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.63391573 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63318405 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62412071 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.61723822 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60371672 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.59771518 |
| 53 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59062903 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.58685808 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.57415665 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55734331 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54186691 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54048676 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53572990 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.53385294 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51534780 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49492346 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48918301 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.44400210 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44196099 |
| 66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.40618287 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36034560 |
| 68 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35186471 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34270926 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34071482 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31857460 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.31399116 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30266395 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30077676 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29131204 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28224269 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27741332 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24591441 |
| 79 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24342215 |
| 80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23838765 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23622485 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23622485 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 1.23616835 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23216469 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23138945 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22868506 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 1.22309615 |
| 88 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21567980 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21268762 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20883244 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19963862 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19129544 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17819732 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17733548 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16498277 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16339651 |
| 97 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15051687 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14052200 |
| 99 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13699606 |
| 100 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13699606 |
| 101 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13685631 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13323716 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13179983 |
| 104 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.13020908 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11300033 |
| 106 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10790878 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10503584 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09393589 |
| 109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09350707 |
| 110 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08377984 |
| 111 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08198656 |
| 112 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08095814 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07960625 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07857896 |
| 115 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07493861 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06111019 |
| 117 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.05094488 |
| 118 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04917068 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02042550 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01928487 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01403458 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00951233 |
| 123 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00631556 |
| 124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00284763 |
| 125 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99890851 |
| 126 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99849048 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99416632 |
| 128 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99165264 |
| 129 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99160578 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98502851 |
| 131 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98203211 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98033763 |
| 133 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97927369 |
| 134 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97427897 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97281403 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96865555 |
| 137 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.96789027 |
| 138 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96691583 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95992466 |
| 140 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95961049 |
| 141 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95847417 |
| 142 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95801819 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95764813 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95707773 |
| 145 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95433786 |
| 146 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95253895 |
| 147 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95246755 |
| 148 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94835161 |
| 149 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94703342 |
| 150 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92871848 |
| 151 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92867512 |
| 152 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92802024 |
| 153 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92710138 |
| 154 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92591732 |
| 155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92417777 |
| 156 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92195926 |
| 157 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91639953 |
| 158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91473668 |
| 159 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90964912 |
| 160 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90964912 |
| 161 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90926305 |
| 162 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90922144 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89500795 |
| 164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.89056579 |
| 165 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88472190 |
| 166 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88078713 |
| 167 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87942531 |
| 168 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87942105 |
| 169 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.87869363 |
| 170 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86938073 |
| 171 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86889772 |
| 172 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86553707 |
| 173 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86449855 |
| 174 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86397328 |
| 175 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86362076 |
| 176 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86040419 |
| 177 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85814066 |
| 178 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85301388 |
| 179 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85061871 |
| 180 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84698722 |
| 181 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84393308 |
| 182 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83262172 |
| 183 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82814189 |
| 184 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82267805 |
| 185 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81673815 |
| 186 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80982129 |
| 187 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80800382 |
| 188 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80661220 |
| 189 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79750403 |
| 190 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79334034 |
| 191 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78399815 |
| 192 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76167700 |
| 193 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76095258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.07124844 |
| 2 | MP0003646_muscle_fatigue | 5.80393200 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.65734311 |
| 4 | MP0000751_myopathy | 5.24940224 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.96147258 |
| 6 | MP0002132_abnormal_respiratory_system | 4.49447108 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.14705646 |
| 8 | MP0004036_abnormal_muscle_relaxation | 4.09285117 |
| 9 | MP0005330_cardiomyopathy | 3.82576987 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 3.41770252 |
| 11 | MP0005464_abnormal_platelet_physiology | 3.40887072 |
| 12 | MP0000749_muscle_degeneration | 3.38957872 |
| 13 | MP0009278_abnormal_bone_marrow | 3.12022527 |
| 14 | MP0002972_abnormal_cardiac_muscle | 3.11658247 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 3.09591475 |
| 16 | MP0009697_abnormal_copulation | 3.02753165 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.97358779 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.95562596 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.93496654 |
| 20 | MP0004484_altered_response_of | 2.77544909 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.76935793 |
| 22 | MP0006054_spinal_hemorrhage | 2.67223270 |
| 23 | MP0004130_abnormal_muscle_cell | 2.61669590 |
| 24 | * MP0005385_cardiovascular_system_phenoty | 2.60062899 |
| 25 | * MP0001544_abnormal_cardiovascular_syste | 2.60062899 |
| 26 | MP0005620_abnormal_muscle_contractility | 2.56037828 |
| 27 | MP0006138_congestive_heart_failure | 2.51612691 |
| 28 | MP0003436_decreased_susceptibility_to | 2.50012314 |
| 29 | * MP0010630_abnormal_cardiac_muscle | 2.49422112 |
| 30 | * MP0002106_abnormal_muscle_physiology | 2.27756374 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 2.22613851 |
| 32 | MP0001968_abnormal_touch/_nociception | 2.21854659 |
| 33 | MP0004085_abnormal_heartbeat | 2.20917112 |
| 34 | MP0003828_pulmonary_edema | 2.19591269 |
| 35 | MP0002269_muscular_atrophy | 2.12102429 |
| 36 | MP0004510_myositis | 2.11237142 |
| 37 | MP0000678_abnormal_parathyroid_gland | 2.06959500 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.99231404 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.92380787 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.90952752 |
| 41 | MP0000613_abnormal_salivary_gland | 1.88935059 |
| 42 | * MP0005369_muscle_phenotype | 1.86799257 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.85501150 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.83055742 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.82912199 |
| 46 | MP0000747_muscle_weakness | 1.76634485 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.72916001 |
| 48 | MP0000467_abnormal_esophagus_morphology | 1.70851506 |
| 49 | MP0009053_abnormal_anal_canal | 1.69566102 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.67002410 |
| 51 | MP0001764_abnormal_homeostasis | 1.64572943 |
| 52 | MP0002009_preneoplasia | 1.64214788 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.61616002 |
| 54 | MP0004233_abnormal_muscle_weight | 1.59762454 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.58806532 |
| 56 | MP0002127_abnormal_cardiovascular_syste | 1.54147990 |
| 57 | MP0003252_abnormal_bile_duct | 1.51544852 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.49850386 |
| 59 | MP0008058_abnormal_DNA_repair | 1.47036707 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.40120916 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.37794967 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.34381488 |
| 63 | MP0000343_altered_response_to | 1.32941027 |
| 64 | MP0002234_abnormal_pharynx_morphology | 1.32565724 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.27815101 |
| 66 | MP0003279_aneurysm | 1.27255074 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.25741836 |
| 68 | MP0005165_increased_susceptibility_to | 1.25529167 |
| 69 | MP0003724_increased_susceptibility_to | 1.24046682 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.23754026 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.23545533 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.21278464 |
| 73 | MP0003075_altered_response_to | 1.20097022 |
| 74 | MP0008004_abnormal_stomach_pH | 1.15718315 |
| 75 | MP0010368_abnormal_lymphatic_system | 1.15549459 |
| 76 | MP0001664_abnormal_digestion | 1.15361420 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.13187954 |
| 78 | MP0003638_abnormal_response/metabolism_ | 1.12531643 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 1.12288021 |
| 80 | * MP0000266_abnormal_heart_morphology | 1.12072702 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 1.10966064 |
| 82 | MP0005670_abnormal_white_adipose | 1.10790611 |
| 83 | MP0009764_decreased_sensitivity_to | 1.09203230 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.07499257 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.07499257 |
| 86 | MP0005623_abnormal_meninges_morphology | 1.05778285 |
| 87 | MP0000516_abnormal_urinary_system | 1.03894922 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 1.03894922 |
| 89 | MP0003186_abnormal_redox_activity | 1.03435377 |
| 90 | MP0004858_abnormal_nervous_system | 1.01483838 |
| 91 | MP0000470_abnormal_stomach_morphology | 1.01122133 |
| 92 | MP0002102_abnormal_ear_morphology | 1.01042730 |
| 93 | MP0005375_adipose_tissue_phenotype | 1.00693381 |
| 94 | MP0003283_abnormal_digestive_organ | 0.98851242 |
| 95 | MP0003303_peritoneal_inflammation | 0.97219540 |
| 96 | MP0005410_abnormal_fertilization | 0.95936312 |
| 97 | MP0005275_abnormal_skin_tensile | 0.95897072 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.95142191 |
| 99 | MP0003718_maternal_effect | 0.94776802 |
| 100 | MP0001905_abnormal_dopamine_level | 0.93033529 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.92706537 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.91428628 |
| 103 | MP0002282_abnormal_trachea_morphology | 0.90842207 |
| 104 | MP0003866_abnormal_defecation | 0.90323809 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.89837367 |
| 106 | MP0002928_abnormal_bile_duct | 0.88571944 |
| 107 | MP0005390_skeleton_phenotype | 0.83133214 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.82922094 |
| 109 | MP0000685_abnormal_immune_system | 0.81990185 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.81363110 |
| 111 | MP0008872_abnormal_physiological_respon | 0.78990784 |
| 112 | * MP0002128_abnormal_blood_circulation | 0.78444740 |
| 113 | MP0004133_heterotaxia | 0.78204606 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.78185202 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.78109287 |
| 116 | * MP0003567_abnormal_fetal_cardiomyocyte | 0.76327536 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.75635998 |
| 118 | MP0001293_anophthalmia | 0.75234018 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.73407517 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.73268958 |
| 121 | MP0002166_altered_tumor_susceptibility | 0.73236826 |
| 122 | MP0002933_joint_inflammation | 0.73024974 |
| 123 | MP0006292_abnormal_olfactory_placode | 0.72934120 |
| 124 | MP0002160_abnormal_reproductive_system | 0.72465423 |
| 125 | MP0005187_abnormal_penis_morphology | 0.72200364 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.71235152 |
| 127 | MP0002822_catalepsy | 0.71157525 |
| 128 | MP0005266_abnormal_metabolism | 0.70974762 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.67667058 |
| 130 | MP0001881_abnormal_mammary_gland | 0.66438078 |
| 131 | MP0003119_abnormal_digestive_system | 0.66341493 |
| 132 | MP0008873_increased_physiological_sensi | 0.65760231 |
| 133 | MP0002398_abnormal_bone_marrow | 0.64643888 |
| 134 | MP0005503_abnormal_tendon_morphology | 0.64275625 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.64026936 |
| 136 | MP0002932_abnormal_joint_morphology | 0.63844901 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.63570800 |
| 138 | MP0000733_abnormal_muscle_development | 0.63428905 |
| 139 | MP0000013_abnormal_adipose_tissue | 0.63188627 |
| 140 | MP0003693_abnormal_embryo_hatching | 0.62481811 |
| 141 | MP0003315_abnormal_perineum_morphology | 0.62033461 |
| 142 | MP0004272_abnormal_basement_membrane | 0.60914886 |
| 143 | MP0000003_abnormal_adipose_tissue | 0.60295842 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.57811177 |
| 145 | MP0004043_abnormal_pH_regulation | 0.55908638 |
| 146 | MP0004924_abnormal_behavior | 0.49329466 |
| 147 | MP0005386_behavior/neurological_phenoty | 0.49329466 |
| 148 | MP0002971_abnormal_brown_adipose | 0.47418764 |
| 149 | MP0004147_increased_porphyrin_level | 0.46456568 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.46251672 |
| 151 | MP0001958_emphysema | 0.46069238 |
| 152 | MP0005535_abnormal_body_temperature | 0.45919071 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.45800089 |
| 154 | MP0002925_abnormal_cardiovascular_devel | 0.45125365 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.44349720 |
| 156 | MP0002295_abnormal_pulmonary_circulatio | 0.42998899 |
| 157 | MP0005319_abnormal_enzyme/_coenzyme | 0.37962597 |
| 158 | MP0003045_fibrosis | 0.37630475 |
| 159 | MP0001614_abnormal_blood_vessel | 0.36617385 |
| 160 | MP0008874_decreased_physiological_sensi | 0.35238480 |
| 161 | MP0003806_abnormal_nucleotide_metabolis | 0.32637309 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.31904821 |
| 163 | MP0008569_lethality_at_weaning | 0.30660196 |
| 164 | * MP0003984_embryonic_growth_retardation | 0.30404521 |
| 165 | * MP0002088_abnormal_embryonic_growth/wei | 0.29342734 |
| 166 | MP0008961_abnormal_basal_metabolism | 0.29310881 |
| 167 | MP0001853_heart_inflammation | 0.29097068 |
| 168 | MP0001784_abnormal_fluid_regulation | 0.28450720 |
| 169 | MP0002877_abnormal_melanocyte_morpholog | 0.27988373 |
| 170 | MP0001727_abnormal_embryo_implantation | 0.27874364 |
| 171 | MP0005388_respiratory_system_phenotype | 0.25828263 |
| 172 | MP0002133_abnormal_respiratory_system | 0.25828263 |
| 173 | MP0003948_abnormal_gas_homeostasis | 0.24686864 |
| 174 | MP0001529_abnormal_vocalization | 0.22387134 |
| 175 | MP0002090_abnormal_vision | 0.21961778 |
| 176 | MP0003091_abnormal_cell_migration | 0.21726248 |
| 177 | MP0005334_abnormal_fat_pad | 0.21592324 |
| 178 | MP0005167_abnormal_blood-brain_barrier | 0.21444186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.11854388 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.21823397 |
| 3 | Atrial fibrillation (HP:0005110) | 6.47134192 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 6.07245023 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 6.05515541 |
| 6 | Supraventricular tachycardia (HP:0004755) | 5.89972878 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 5.78118418 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.56404503 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.42570452 |
| 10 | Lipoatrophy (HP:0100578) | 5.35984500 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.34215853 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.16280571 |
| 13 | Syncope (HP:0001279) | 5.11657484 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.11555404 |
| 15 | Bundle branch block (HP:0011710) | 5.07231479 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 5.05084614 |
| 17 | Palpitations (HP:0001962) | 4.70384044 |
| 18 | Myoglobinuria (HP:0002913) | 4.60377974 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.48641074 |
| 20 | Dilated cardiomyopathy (HP:0001644) | 4.42816126 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.33731064 |
| 22 | Subaortic stenosis (HP:0001682) | 4.33731064 |
| 23 | Prolonged QT interval (HP:0001657) | 4.31615495 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 4.21702974 |
| 25 | Heart block (HP:0012722) | 4.14036965 |
| 26 | Colon cancer (HP:0003003) | 4.09111933 |
| 27 | Increased connective tissue (HP:0009025) | 4.07594188 |
| 28 | Atrioventricular block (HP:0001678) | 4.04989823 |
| 29 | Ventricular arrhythmia (HP:0004308) | 4.03855747 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.94191239 |
| 31 | Ventricular fibrillation (HP:0001663) | 3.81816076 |
| 32 | Thrombocytosis (HP:0001894) | 3.78763843 |
| 33 | Hyperglycinuria (HP:0003108) | 3.77501963 |
| 34 | EMG: myopathic abnormalities (HP:0003458) | 3.68493365 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.64140740 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.63238187 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.51991239 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.47526316 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.47526316 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 3.47526316 |
| 41 | Abnormal glycosylation (HP:0012345) | 3.47526316 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 3.44609486 |
| 43 | Difficulty running (HP:0009046) | 3.42480036 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 3.28658252 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 3.28658252 |
| 46 | Spontaneous abortion (HP:0005268) | 3.28375877 |
| 47 | Myotonia (HP:0002486) | 3.25004711 |
| 48 | Chronic otitis media (HP:0000389) | 3.23458413 |
| 49 | Abnormal EKG (HP:0003115) | 3.14990413 |
| 50 | Hepatic necrosis (HP:0002605) | 3.12842978 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10516281 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07656686 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 3.06972326 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 3.05025576 |
| 55 | Abnormality of the prostate (HP:0008775) | 3.01636670 |
| 56 | Difficulty climbing stairs (HP:0003551) | 3.01189879 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 2.96693485 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.88587618 |
| 59 | Ketoacidosis (HP:0001993) | 2.82325874 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80744613 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.80744613 |
| 62 | Prostate neoplasm (HP:0100787) | 2.80093101 |
| 63 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.79940688 |
| 64 | Stomach cancer (HP:0012126) | 2.79695068 |
| 65 | Pustule (HP:0200039) | 2.77859329 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.74918388 |
| 67 | Rough bone trabeculation (HP:0100670) | 2.71005251 |
| 68 | Increased IgM level (HP:0003496) | 2.70416158 |
| 69 | Acute encephalopathy (HP:0006846) | 2.63833973 |
| 70 | B lymphocytopenia (HP:0010976) | 2.63023627 |
| 71 | Seborrheic dermatitis (HP:0001051) | 2.61947572 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.61868925 |
| 73 | Abnormality of macular pigmentation (HP:0008002) | 2.60292740 |
| 74 | Palmoplantar keratoderma (HP:0000982) | 2.59191327 |
| 75 | Bifid tongue (HP:0010297) | 2.58490071 |
| 76 | Progressive macrocephaly (HP:0004481) | 2.57864335 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57644530 |
| 78 | Amaurosis fugax (HP:0100576) | 2.57071100 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56412978 |
| 80 | Mitochondrial inheritance (HP:0001427) | 2.53694053 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.50950351 |
| 82 | Testicular atrophy (HP:0000029) | 2.50054612 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.49232863 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.48169015 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.44745642 |
| 86 | Conjunctival hamartoma (HP:0100780) | 2.44101824 |
| 87 | Epistaxis (HP:0000421) | 2.44030904 |
| 88 | Limb-girdle muscle atrophy (HP:0003797) | 2.43761307 |
| 89 | Cerebral edema (HP:0002181) | 2.43035576 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42549214 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.42549214 |
| 92 | Pheochromocytoma (HP:0002666) | 2.37974871 |
| 93 | Increased CSF lactate (HP:0002490) | 2.35335985 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35090274 |
| 95 | Mesangial abnormality (HP:0001966) | 2.30778049 |
| 96 | Broad metatarsal (HP:0001783) | 2.28930139 |
| 97 | Squamous cell carcinoma (HP:0002860) | 2.28187646 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.27803229 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27084547 |
| 100 | Abnormality of alanine metabolism (HP:0010916) | 2.27084547 |
| 101 | Hyperalaninemia (HP:0003348) | 2.27084547 |
| 102 | Chest pain (HP:0100749) | 2.23727107 |
| 103 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.22669060 |
| 104 | Sudden cardiac death (HP:0001645) | 2.22549757 |
| 105 | Respiratory failure (HP:0002878) | 2.22231276 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20983017 |
| 107 | Acute lymphatic leukemia (HP:0006721) | 2.20514389 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19734731 |
| 109 | Dysmetric saccades (HP:0000641) | 2.17329070 |
| 110 | Abnormality of male internal genitalia (HP:0000022) | 2.16801087 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 2.16005994 |
| 112 | Neuroendocrine neoplasm (HP:0100634) | 2.15205505 |
| 113 | Lactic acidosis (HP:0003128) | 2.13469223 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 2.13275387 |
| 115 | Muscle stiffness (HP:0003552) | 2.12356406 |
| 116 | Dyschromatopsia (HP:0007641) | 2.10914035 |
| 117 | Hamartoma of the eye (HP:0010568) | 2.08224343 |
| 118 | Hypoplasia of the pons (HP:0012110) | 2.05930618 |
| 119 | Congestive heart failure (HP:0001635) | 2.05692750 |
| 120 | Exercise intolerance (HP:0003546) | 2.05575517 |
| 121 | Renal Fanconi syndrome (HP:0001994) | 2.04534384 |
| 122 | Ketosis (HP:0001946) | 2.04131095 |
| 123 | Areflexia of lower limbs (HP:0002522) | 2.03789556 |
| 124 | Portal hypertension (HP:0001409) | 2.03548073 |
| 125 | Abnormality of lateral ventricle (HP:0030047) | 2.00065432 |
| 126 | Renal cortical cysts (HP:0000803) | 1.99272610 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 1.98536029 |
| 128 | Pancytopenia (HP:0001876) | 1.96560005 |
| 129 | Alveolar cell carcinoma (HP:0006519) | 1.96040820 |
| 130 | Intrahepatic cholestasis (HP:0001406) | 1.95063299 |
| 131 | Abnormality of the pons (HP:0007361) | 1.93665985 |
| 132 | Abnormality of glycolysis (HP:0004366) | 1.91380770 |
| 133 | Increased serum pyruvate (HP:0003542) | 1.91380770 |
| 134 | Neoplasm of the adrenal gland (HP:0100631) | 1.90458446 |
| 135 | Muscular dystrophy (HP:0003560) | 1.90104092 |
| 136 | Neoplasm of head and neck (HP:0012288) | 1.90047834 |
| 137 | Esophageal neoplasm (HP:0100751) | 1.90047834 |
| 138 | Neoplasm of the pancreas (HP:0002894) | 1.89749588 |
| 139 | Ulnar claw (HP:0001178) | 1.88937336 |
| 140 | Pancreatic fibrosis (HP:0100732) | 1.88718446 |
| 141 | Nephronophthisis (HP:0000090) | 1.87037221 |
| 142 | Hypoplastic ischia (HP:0003175) | 1.86756678 |
| 143 | Lipid accumulation in hepatocytes (HP:0006561) | 1.84621332 |
| 144 | Increased cerebral lipofuscin (HP:0011813) | 1.84176814 |
| 145 | Large for gestational age (HP:0001520) | 1.84147056 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83733174 |
| 147 | Gowers sign (HP:0003391) | 1.83237651 |
| 148 | Amelogenesis imperfecta (HP:0000705) | 1.81284273 |
| 149 | Gonadal dysgenesis (HP:0000133) | 1.81016135 |
| 150 | Abnormality of the hepatic vasculature (HP:0006707) | 1.80439686 |
| 151 | Neck muscle weakness (HP:0000467) | 1.79553902 |
| 152 | Tinnitus (HP:0000360) | 1.79127904 |
| 153 | Agammaglobulinemia (HP:0004432) | 1.78779152 |
| 154 | Lymphangioma (HP:0100764) | 1.78437634 |
| 155 | Abnormality of the foot musculature (HP:0001436) | 1.77903543 |
| 156 | Neoplasm of the adrenal cortex (HP:0100641) | 1.76569477 |
| 157 | Athetosis (HP:0002305) | 1.76297396 |
| 158 | Foot dorsiflexor weakness (HP:0009027) | 1.75717321 |
| 159 | Bone marrow hypocellularity (HP:0005528) | 1.74155956 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.74131246 |
| 161 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73797529 |
| 162 | Poikiloderma (HP:0001029) | 1.73716494 |
| 163 | Absent/shortened dynein arms (HP:0200106) | 1.73034217 |
| 164 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73034217 |
| 165 | Pancreatic cysts (HP:0001737) | 1.72622753 |
| 166 | Increased hepatocellular lipid droplets (HP:0006565) | 1.72232513 |
| 167 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72012601 |
| 168 | Lethargy (HP:0001254) | 1.71080332 |
| 169 | Clumsiness (HP:0002312) | 1.70854237 |
| 170 | Myelodysplasia (HP:0002863) | 1.70829042 |
| 171 | Central scotoma (HP:0000603) | 1.70103848 |
| 172 | Hypertensive crisis (HP:0100735) | 1.69792536 |
| 173 | Granulocytopenia (HP:0001913) | 1.69633965 |
| 174 | Tubulointerstitial nephritis (HP:0001970) | 1.69290120 |
| 175 | Abnormal trabecular bone morphology (HP:0100671) | 1.67926399 |
| 176 | Severe combined immunodeficiency (HP:0004430) | 1.67536974 |
| 177 | Poor eye contact (HP:0000817) | 1.67271749 |
| 178 | Asplenia (HP:0001746) | 1.66336174 |
| 179 | Prominent supraorbital ridges (HP:0000336) | 1.64866567 |
| 180 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.64772114 |
| 181 | Increased serum lactate (HP:0002151) | 1.64616928 |
| 182 | Bulbous nose (HP:0000414) | 1.64523292 |
| 183 | Facial diplegia (HP:0001349) | 1.64148968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.14979393 |
| 2 | VRK2 | 5.32012611 |
| 3 | LMTK2 | 4.27598135 |
| 4 | MYLK | 4.00435116 |
| 5 | PHKG2 | 3.83488193 |
| 6 | PHKG1 | 3.83488193 |
| 7 | TAF1 | 3.67026476 |
| 8 | PDK3 | 3.43221107 |
| 9 | PDK4 | 3.43221107 |
| 10 | PKN2 | 3.09885933 |
| 11 | DMPK | 3.09699013 |
| 12 | TRIB3 | 3.02847917 |
| 13 | NUAK1 | 2.99385773 |
| 14 | CDK8 | 2.51405746 |
| 15 | TEC | 2.49843500 |
| 16 | OBSCN | 2.49478007 |
| 17 | VRK1 | 2.44680706 |
| 18 | BCKDK | 2.41041739 |
| 19 | SMG1 | 2.39989245 |
| 20 | TIE1 | 2.22197748 |
| 21 | MAP4K1 | 2.21221809 |
| 22 | BUB1 | 2.18844809 |
| 23 | PIK3CA | 2.18279073 |
| 24 | MUSK | 2.18039923 |
| 25 | MAPKAPK5 | 2.15851355 |
| 26 | PBK | 2.13838802 |
| 27 | GRK7 | 2.05594856 |
| 28 | PDK2 | 2.03020309 |
| 29 | ERN1 | 1.96338633 |
| 30 | NEK1 | 1.90555546 |
| 31 | CDK9 | 1.88871688 |
| 32 | DAPK1 | 1.88710264 |
| 33 | PINK1 | 1.80277436 |
| 34 | KIT | 1.78287865 |
| 35 | STK24 | 1.75428854 |
| 36 | PAK3 | 1.70300183 |
| 37 | TBK1 | 1.70126512 |
| 38 | BRSK2 | 1.66317808 |
| 39 | TGFBR1 | 1.65054290 |
| 40 | BMPR1B | 1.64660982 |
| 41 | JAK3 | 1.46984065 |
| 42 | FES | 1.46571388 |
| 43 | MKNK1 | 1.46542174 |
| 44 | CAMK2D | 1.40678675 |
| 45 | PRKD1 | 1.35376378 |
| 46 | WEE1 | 1.31270919 |
| 47 | ITK | 1.28040366 |
| 48 | BTK | 1.21566939 |
| 49 | ILK | 1.14154286 |
| 50 | TRPM7 | 1.10988709 |
| 51 | DAPK2 | 1.01731211 |
| 52 | SYK | 1.01560600 |
| 53 | MAPKAPK3 | 1.00665921 |
| 54 | WNK4 | 1.00428386 |
| 55 | PDGFRA | 0.98351357 |
| 56 | IKBKB | 0.96733754 |
| 57 | ADRBK2 | 0.96642856 |
| 58 | MAP3K5 | 0.94804190 |
| 59 | ROCK1 | 0.93351415 |
| 60 | TSSK6 | 0.92301355 |
| 61 | CSF1R | 0.90840885 |
| 62 | CAMK4 | 0.90215485 |
| 63 | MAPK12 | 0.88315664 |
| 64 | STK16 | 0.88096543 |
| 65 | EIF2AK2 | 0.87719278 |
| 66 | GRK5 | 0.86653615 |
| 67 | STK4 | 0.86445233 |
| 68 | MAP3K7 | 0.86119992 |
| 69 | DAPK3 | 0.85969038 |
| 70 | MAP3K4 | 0.84819147 |
| 71 | CDC7 | 0.84647018 |
| 72 | PNCK | 0.84407983 |
| 73 | PIK3CG | 0.84200252 |
| 74 | CDC42BPA | 0.83314818 |
| 75 | CDK7 | 0.81785402 |
| 76 | RIPK1 | 0.81204056 |
| 77 | MELK | 0.79641189 |
| 78 | PLK3 | 0.79010906 |
| 79 | CAMK2A | 0.78288378 |
| 80 | DYRK2 | 0.77114297 |
| 81 | STK38L | 0.76867158 |
| 82 | CCNB1 | 0.76843990 |
| 83 | STK38 | 0.76245125 |
| 84 | ARAF | 0.75267548 |
| 85 | CAMKK1 | 0.74650237 |
| 86 | PRKAA1 | 0.73108104 |
| 87 | FLT3 | 0.72392049 |
| 88 | ROCK2 | 0.70301864 |
| 89 | TNK2 | 0.69531993 |
| 90 | PKN1 | 0.65841032 |
| 91 | MAP2K3 | 0.64084581 |
| 92 | GRK1 | 0.63717880 |
| 93 | LCK | 0.63106426 |
| 94 | PRKAA2 | 0.62766699 |
| 95 | RPS6KL1 | 0.62641343 |
| 96 | RPS6KC1 | 0.62641343 |
| 97 | CSNK1G3 | 0.61588667 |
| 98 | CAMK1 | 0.61332937 |
| 99 | FRK | 0.60948161 |
| 100 | MAP2K4 | 0.60578756 |
| 101 | TXK | 0.59760993 |
| 102 | PTK2B | 0.59629887 |
| 103 | TLK1 | 0.59562369 |
| 104 | WNK1 | 0.59446548 |
| 105 | PLK2 | 0.59418272 |
| 106 | PRKD3 | 0.57370649 |
| 107 | PRKCE | 0.56414559 |
| 108 | RPS6KA5 | 0.56099636 |
| 109 | LATS2 | 0.55578103 |
| 110 | SCYL2 | 0.55354634 |
| 111 | TGFBR2 | 0.55025310 |
| 112 | RET | 0.54722322 |
| 113 | PDPK1 | 0.54192392 |
| 114 | EPHB1 | 0.53481763 |
| 115 | PIM2 | 0.53410132 |
| 116 | RPS6KA6 | 0.52541575 |
| 117 | CAMKK2 | 0.52371424 |
| 118 | MAP4K2 | 0.51704544 |
| 119 | PRKCH | 0.50842371 |
| 120 | MAP3K14 | 0.49853948 |
| 121 | PRKACB | 0.49469496 |
| 122 | RPS6KB2 | 0.49195891 |
| 123 | FGFR4 | 0.48803202 |
| 124 | ZAP70 | 0.48043012 |
| 125 | CSNK1G2 | 0.48005481 |
| 126 | MAP3K6 | 0.47929253 |
| 127 | PDK1 | 0.47316251 |
| 128 | LATS1 | 0.46918166 |
| 129 | CSNK1G1 | 0.46705381 |
| 130 | ATR | 0.46325544 |
| 131 | MAP3K3 | 0.45316689 |
| 132 | WNK3 | 0.45225367 |
| 133 | INSRR | 0.44621792 |
| 134 | MAPK15 | 0.43054858 |
| 135 | BRSK1 | 0.42033380 |
| 136 | PRKG2 | 0.41883431 |
| 137 | HIPK2 | 0.41430740 |
| 138 | ADRBK1 | 0.40937079 |
| 139 | KDR | 0.40678258 |
| 140 | PRKACA | 0.38787481 |
| 141 | CAMK2G | 0.38562916 |
| 142 | PRKACG | 0.37807911 |
| 143 | PRKCQ | 0.37428832 |
| 144 | JAK1 | 0.37244972 |
| 145 | CSNK1A1L | 0.36353299 |
| 146 | FER | 0.35500141 |
| 147 | PRKCD | 0.34624224 |
| 148 | MAPK4 | 0.34614528 |
| 149 | KSR2 | 0.34498174 |
| 150 | IGF1R | 0.34319531 |
| 151 | PLK1 | 0.33890769 |
| 152 | SIK1 | 0.33322284 |
| 153 | EEF2K | 0.33251017 |
| 154 | HCK | 0.33133239 |
| 155 | IKBKE | 0.32833767 |
| 156 | TAOK3 | 0.31386921 |
| 157 | PAK6 | 0.31270379 |
| 158 | MST4 | 0.31052431 |
| 159 | ZAK | 0.30424397 |
| 160 | RPS6KA1 | 0.29644981 |
| 161 | AKT2 | 0.29549237 |
| 162 | STK39 | 0.29484626 |
| 163 | MAP3K1 | 0.24774978 |
| 164 | NEK9 | 0.24672990 |
| 165 | JAK2 | 0.23534592 |
| 166 | EPHB2 | 0.23514651 |
| 167 | MAP2K7 | 0.21588444 |
| 168 | SGK3 | 0.20830556 |
| 169 | TAOK1 | 0.20009349 |
| 170 | EPHA3 | 0.19451462 |
| 171 | RPS6KA2 | 0.19269968 |
| 172 | PTK6 | 0.19161649 |
| 173 | PDGFRB | 0.18922629 |
| 174 | MARK2 | 0.18772700 |
| 175 | SGK1 | 0.18636270 |
| 176 | STK11 | 0.16432154 |
| 177 | NME2 | 0.15957503 |
| 178 | MAPK11 | 0.15522334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.83519065 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.02642730 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.01369586 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.58444607 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.38548974 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34901947 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.26985262 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.16487704 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.11532307 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.88200206 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.88068359 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.66670868 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.59173510 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39426216 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.37077109 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.35426178 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 2.35055861 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.27877040 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 2.24225169 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22935476 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18737045 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14658814 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12406418 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 2.12033082 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10115029 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 2.09244545 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.09053426 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 2.06184237 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.93750916 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.93134062 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.85307652 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.83816740 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80895973 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80341546 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76686537 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73896706 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.72870157 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72096370 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65240027 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57204527 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54183381 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51863676 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45108345 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44645712 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 1.43999640 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.43524929 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43002365 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42166771 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42035353 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.40941068 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38825371 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37982558 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33901116 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26876178 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23378908 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20380192 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.19306308 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18955128 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17032573 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17011817 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13937750 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07214495 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04997833 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03715885 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 1.01728356 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01448368 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99515645 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96992118 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95857571 |
| 70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91991713 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91951219 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90049211 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88156222 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85541261 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83790000 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.82198142 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81740165 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81542402 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.80931487 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80540026 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79840452 |
| 82 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74508357 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73769983 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73701903 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73662752 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73074788 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70509997 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.68941836 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68422042 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68208309 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68070316 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66929663 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66820010 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66525989 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65935600 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65518074 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65466429 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.65035618 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64359749 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63560403 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61970172 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61246766 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.61205790 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59574910 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58680003 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58023965 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57217923 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57184062 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56629575 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55326477 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54082304 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52508526 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.50646107 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50557052 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49767708 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48615428 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47609779 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46047539 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46003128 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45206020 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43893531 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43048831 |
| 123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42818494 |
| 124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42231090 |
| 125 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42059523 |
| 126 | Spliceosome_Homo sapiens_hsa03040 | 0.42058899 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40236990 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.39554122 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39382339 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38499395 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38373652 |
| 132 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37438724 |
| 133 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37174224 |
| 134 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.36652851 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36266630 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.35824839 |
| 137 | Gap junction_Homo sapiens_hsa04540 | 0.34621181 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.34186757 |
| 139 | Peroxisome_Homo sapiens_hsa04146 | 0.33710128 |
| 140 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33666848 |
| 141 | Adherens junction_Homo sapiens_hsa04520 | 0.33329003 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33111615 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32048276 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31754261 |
| 145 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30993724 |
| 146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29979928 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29920878 |
| 148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29186280 |
| 149 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28956111 |
| 150 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27440152 |
| 151 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26764407 |
| 152 | Platelet activation_Homo sapiens_hsa04611 | 0.26392016 |
| 153 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26239028 |
| 154 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26092925 |
| 155 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25394282 |
| 156 | Morphine addiction_Homo sapiens_hsa05032 | 0.24916202 |
| 157 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24900149 |
| 158 | Taste transduction_Homo sapiens_hsa04742 | 0.24264577 |
| 159 | Salivary secretion_Homo sapiens_hsa04970 | 0.22935925 |
| 160 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22134426 |
| 161 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20492255 |
| 162 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19717658 |
| 163 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19499051 |
| 164 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16849939 |
| 165 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.16821135 |
| 166 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16672785 |
| 167 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.16389152 |
| 168 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15794529 |
| 169 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.15778008 |
| 170 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14153609 |
| 171 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11763703 |
| 172 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11436954 |
| 173 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10853783 |
| 174 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10781081 |
| 175 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07319600 |

